FDI GLUCOSE CONTROL LEVELS 1, 2 AND 3— 510(k) K092645

Name: FDA 510(k) clearance K092645
Creator: U.S. Food and Drug Administration
Published: 2009-09-05

Substantially Equivalent

Fujirebio Diagnostics,Inc.

FDA 510(k) clearance K092645 for FDI GLUCOSE CONTROL LEVELS 1, 2 AND 3, Substantially Equivalent on 2009-09-05. Applicant: Fujirebio Diagnostics,Inc.. Device class: 1.

Clearance details

Applicant: Fujirebio Diagnostics,Inc.
Product code: Code JJX
Device class: Class 1
Regulation: 21 CFR 862.1660
Advisory panel: Clinical Chemistry
Date received: 2009-08-27
Decision date: 2009-09-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Seguin, TX, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JJX

view all

K170678 — Beta-CrossLaps CalCheck 52017-04-04
K162173 — Elecsys CYFRA 21-1 CalCheck 52017-01-12
K162514 — Multichem A1c2016-10-26
K161874 — Audit MicroControls Linearity DROP LQ Blood Glucose2016-08-10
K161522 — LIAISON EBV IgM Serum Control Set2016-06-30

More clearances from Fujirebio Diagnostics,Inc.

view all

K250925 — ADVIA Centaur Cytokeratin Fragment 21-12025-12-16
K242706 — Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio2025-05-16
DEN200072 — Lumipulse G ß-Amyloid Ratio (1-42/1-40)2022-05-04
K192524 — Lumipulse G CA15-32020-09-04
K192380 — ST AIA-PACK BNP2020-08-24

Adverse events under product code JJX

product code JJX

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.